Neuroprotection Market, By Product Type (Pharmaceuticals, Biologics, Nutraceuticals, and Others), By Mechanism of Action (Antioxidants, Anti-inflammatory Drugs, Neurotransmitter Modulators, Calcium Channel Blockers, NMDA Receptor Antagonists, and Others), By Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Huntington’s Disease, Traumatic Brain Injury (TBI), Ischemic Stroke, Epilepsy, Retinal Degeneration, Glaucoma, Spinal Cord Injuries, and Others), By Patient Demographics (Pediatric Patients, Adult Patients, and Geriatric Patients), By Gender Male and Female), By Route of Administration (Oral, Injectable, Intranasal, Transdermal, and Sublingual), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)